跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Robitussin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Robitussin
Approved
STANDARD
Robitussin
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
afa17298109b40eb
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
afa17298109b40eb
Drug Approval Philippines Name
Robitussin
Product Name
Robitussin
Registration Number
DR-365
Brand Name
Robitussin
Generic Name
Guaifenesin
Dosage Form
Syrup
Dosage Strength
100 mg/5 mL
Manufacturer
Interphil Laboratories, Inc.
Trader
GlaxoSmithKline Consumer Healthcare Philippines, Inc.
Issuance Date
29 March 2021
Expiry Date
22 February 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
afa17298109b40eb
Type
Standard
Back to Philippines FDA Approvals